Skip to main content
  • Yolanda-Scarlett

    Scarlett Named Director for Underrepresented Trainee Access and Success

    The UNC School of Medicine’s Office of Diversity, Equity, and Inclusion has named Yolanda Scarlett, MD, as the new Director for Underrepresented Trainee Access and Success. Scarlett is a proud alumnus of the UNC School of Medicine, as well as a graduate of the UNC Department of Internal Medicine Residency and Gastroenterology Fellowship. She is … Continued

  • cene_Crystal

    Health Equity Speaker Series Features Dr. Crystal Cené and Angela R. Bryant

    Crystal Cené, MD, MPH, UNC Health System Executive Director for Health Equity and associate professor of medicine in the division of general medicine and clinical epidemiology, will lead a health equity speaker series with Angela R. Bryant, JD. The virtual seminar “Can we really advance Health Equity? Five key strategies to consider” is scheduled for … Continued

  • Zeidner-Serody

    Immunotherapy After High-Dose Chemotherapy Leads to Favorable Outcomes in Acute Myeloid Leukemia

    A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab benefited patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer. The findings were published in Blood Cancer Discovery, a journal of the … Continued

  • weber-860x574-1-600x400-1.jpeg

    Weber Study of UV Disinfection Technologies Referenced in Market Research News

    A study by David Weber, MD, MPH, which offers key insights on UV disinfection technologies, was referenced in a press release that recognizes the global UV disinfection equipment market is expected to reach $6.73 billion by 2025.  Weber’s study considered the specifics of manual cleaning, disinfection, and polychromatic actions. Weber is professor of medicine in … Continued

  • david-wohl

    COVID Vaccine Updates Feature David Wohl

    David Wohl, MD, professor of medicine in the division of infectious diseases, was featured in a number of COVID-19 articles the week of September 10-15. NC Reacts to COVID Vaccine Order – News & Observer (September 11, 2021) As political, medical and business leaders in North Carolina show mixed reactions to President Joe Biden’s new … Continued

  • DeWalt-Ammerman-Berkowitz

    Blue Cross NC, UNC Health Join Forces for New Clinical Study to Improve Food Security, Chronic Health Conditions

    Blue Cross and Blue Shield of North Carolina (Blue Cross NC) has dedicated $3.2 million for a new, large clinical study to address food insecurity among its at-risk members who also have hypertension. The study will measure how to best help people who are food insecure achieve better health through nutrition. UNC-Chapel Hill researchers are … Continued

  • David Weber, MD, MPH

    Durham School Board Will Collect Vaccination Data Before Deciding Whether to Mandate Vaccines for its Employees

    Indyweek covered a recent Durham public school board meeting designed to weigh the pros and cons of requiring mandatory COVID vaccine shots for teachers and staff. The board members opted to develop a plan of action based on data that will indicate what percentage of school employees have already received the vaccine. David Weber, MD, … Continued

  • david-wohl

    Governor Cooper Signs Executive Order Aimed to Expand Access to COVID-19 Antibody Treatment

    Governor Roy Cooper signed an executive order expanding access to monoclonal antibody treatments that have the potential to prevent people from dying of COVID-19. The emergency-use treatment is used on high-risk COVID-19 patients who experience symptoms within 10 days of testing positive. This treatment is reported to be similar to what was used on former … Continued

  • Giselle Corbie-Smith, MD, MSc

    Giselle Corbie-Smith Receives Outstanding Faculty Staff Award

    Giselle Corbie-Smith, MD, Kenan Distinguished Professor in the Departments of Medicine and Social Medicine, has received the 2021 McClinton Outstanding Faculty Staff Award. Corbie-Smith is nationally known for her scholarly work on the inclusion of disparity populations in research and has over a decade of experience in using community engagement to conduct innovative, translational health equity … Continued

  • leigh-callahan

    The OA Action Alliance, Arthritis Foundation, and CDC Release ‘Action Briefs’ Focused on Osteoarthritis

    Newly released Action Briefs now make it easier for employers, insurers, healthcare systems, policy makers, and leaders in other organizations to take specific, practical actions to support their constituents with osteoarthritis. The Osteoarthritis Action Alliance (OAAA), partnering with the Centers for Disease Control and Prevention (CDC) and the Arthritis Foundation, issued A National Public Health … Continued

  • Wohl-BRII-Biosciences-Credit-WRAL-News

    UNC Antibody Treatment Could Reduce COVID-19 Hospitalizations By Nearly 80%

    Researchers with the University of North Carolina at Chapel Hill are looking into a new treatment for COVID-19. Vice chair of the study, Dr. David Wohl, professor of medicine in the division of infectious diseases, says the monoclonal antibody cocktail is able to attach to the virus and prevent it from hurting people. Watch the … Continued

  • David Wohl, MD

    Durham’s Brii Biosciences Bets $100M to Advance Possible COVID Therapy

    A WRAL TechWire report says Brii Biosciences, which has operations in Durham as well as Beijing, has announced its commitment to support a combination therapy called BRII-196/BRII-198. “So far, this therapy and other monoclonal antibodies show effectiveness against the Delta variant, which now accounts for almost all the COVID-19 cases in the U.S.,” said David … Continued

  • david-wohl

    News and Observer Consults Experts About Attending Large Events

    As college football stadiums across the nation fill up with cheering fans and limited masking, a Raleigh News & Observer article asks the experts about virus spread. David Wohl, MD, professor of medicine in the division of infectious diseases responded. “Delta is a game-changer (pun intended). This variant is hyper-infectious and hyper-dangerous. That means the things … Continued

  • weber-860x574-1-600x400-1.jpeg

    Weber Explains UV Light, New LARQ Bottle Designed to Deliver Clean Water

    David Weber, MD, MPH, professor of medicine in the division of infectious diseases, commented on UV light technology, which is used in the LARQ Bottle. The new bottle was designed to give people around the world access to pristine drinking water, easily and sustainably. A news report in King Weekly Sentinel reports the bottle’s technology activates every … Continued

  • Booster Shots Could Start September 20

    Dr. Anthony Fauci, America’s top infectious disease expert, said he believes booster shots will be available for Americans starting Sept. 20 – but not everyone will be able to get a dose right away. David Wohl, MD, professor of medicine in the division of infectious diseases, answered questions about booster shots on FOX-46, Good Day … Continued

  • david-wohl

    September Could Be Worst Month For COVID Hospitalizations Yet

    WRAL reports that evidence is mounting to show the fight against COVID-19 in North Carolina could be about to enter uncharted waters. “We’re in the place we are now, a place of surge, a place of pain, a place of chaos, because, to be truthful, we have so many people unvaccinated,” said David Wohl, MD, … Continued

  • Shakira_Grant-1-200x300

    Grant Receives $200,000 to Study Impact of Multiple Myeloma on Older Adult Patients, Care Partners

    The National Institute on Aging has awarded Shakira Grant, MBBS, and the UNC Center for Aging and Health a 2-year, $200,000 grant to study the illness and treatment experiences and functional trajectories of older adults with multiple myeloma and their care partners. Grant is assistant professor in the divisions of hematology and geriatric medicine. Multiple … Continued

  • Richard Boucher

    Carolina Researchers Lead CZI Collaborative on Childhood Diseases

    Principal investigators James Hagood, MD, professor of pediatrics and Richard Boucher, MD, the James C. Moeser Eminent Professor of Medicine in the division of pulmonary diseases and critical care medicine will lead a multinational, $3.5-million project funded through the Chan Zuckerberg Initiative to map crucial cellular roles in human health and disease. The Chan Zuckerberg Initiative … Continued

  • Wohl-News-Interview-Credit-WTVD

    Should We Focus on Getting Vaccines For Kids or Booster Shots for Adults?

    David Wohl, MD, professor of medicine in the division of infectious diseases, talked with ABC-11 about COVID-19 models and when cases might peak. He also answered questions about vaccines for kids and booster shots for adults. Watch the news story.

  • Jessica Lin, MD, MSCR

    Which Type of Immunity Is Best Against Variants? More Symptoms, More Spread and Other COVID-19 News

    An article in Infection Disease Special Edition reviews recent studies about COVID-19 transmission, including one led by Jessica Lin, MD, that showed COVID-19 spreads quickly through a household. The observational study, conducted between April and October 2020, followed 100 patients who tested positive for COVID-19 around the Raleigh, N.C., area and included a total of 208 additional household … Continued

  • david-wohl

    Cooper Promises Expanded Access to COVID Antibody Treatment

    On the same day North Carolina hospitals reported a record number of COVID-19 patients in intensive care units across the state, Gov. Roy Cooper signaled he will take action expanding access to a potentially lifesaving treatment designed to keep people out of the hospital in the first place. “We’ve been beating the drum for months … Continued

  • David Weber, MD, MPH

    How Safe Are Outdoor Events? Is a Lockdown Coming?

    Eighteen months into the pandemic and there are still a lot of questions out there about everything related to COVID-19. CBS 17 took those questions to health experts to get answers using facts not fear. David Weber, MD, MPH, professor of medicine in the division of infectious diseases, contributed to the question and answer segment. … Continued

  • QA-David-Wohl

    Experimental Monoclonal Antibody Combo Shows Significant Efficacy Against COVID-19

    As part of the NIH-sponsored ACTIV-2 clinical trial for COVID-19 outpatients, preliminary data revealed that a new combination monoclonal antibody treatment reduced hospitalizations and death by 78 percent in high-risk patients. ACTIV-2 vice chair David Wohl, MD, leads monoclonal treatment for UNC Health. Read more from the UNC Health and UNC School of Medicine Newsroom.

  • hobbs-duncan

    Hobbs and Duncan Win $3.9M NIAID Grant to Study a Meningitis Vaccine’s Effect on Gonorrhea

    The NIH’s National Institute of Allergy and Infectious Diseases has awarded Marcia Hobbs, PhD, and Alex Duncan, MD, PhD, a five-year, $3.9 million grant to study how a vaccine recently developed to prevent life-threatening infections caused by group B Neisseria meningitidis, the MenB vaccine, may also protect people from infection with Neisseria gonorrhoeae, a sexually … Continued